Ideaya Biosciences Inc. logo

Ideaya Biosciences Inc. (IDYA)

Market Closed
10 Sep, 20:00
NASDAQ (NGS) NASDAQ (NGS)
$
37. 45
-0.9
-2.3468%
Pre Market
$
38. 88
+1.43 +3.8184%
3.79B Market Cap
- P/E Ratio
- Div Yield
534,014 Volume
-1.91 Eps
$ 38.35
Previous Close
Add Transaction
Day Range
37.37 38.41
Year Range
24.24 42.68
Want to track IDYA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Ideaya Biosciences Inc. (IDYA) Statistics

Valuation metrics

Market Cap 3.79B
Enterprise value 3.55B
Trailing P/E (ttm) -20.76
Forward P/E -7.6
PEG ratio -1.05
Price/Sales (ttm) 16.19
Price/Book (mrq) 3.06
Enterprise Value/Revenue 15.15
Enterprise Value/EBITDA -16.69

Overview

Shares outstanding 87.86M
Float 87.01M
Shares short 11.71M
% Held by insiders 0.02%
% Held by institutions 1.11%
Average volume (10 days) 667.35K
Average volume (90 days) 804.56K

Price summary

52-Week low 24.24
52-Week high 42.68
Beta -0.04
50-Day moving average 37.83
200-Day moving average 32.4

Financials

Fiscal year

Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026

Profitability

Profit margin -0.75%
Operating margin -0.93%

Operational effectiveness

Return on assets -0.13%
Return on equity -0.16%

Income Statement

Revenue (ttm) 225.27M
Revenue per share (ttm) 2.54
Quarterly revenue growth (yoy) 0.55%
Gross profit (ttm) -114.27M
EBITDA -180.68M
Net income to common (ttm) -140.06M
Diluted EPS (ttm) -1.9
Quarterly earnings growth (yoy) 0.55%

Balance Sheet

Total cash (mrq) 671.2M
Total cash per share (mrq) 9
Total debt (mrq) 28.6M
Total Debt/Equity (mrq) 0.02
Current ratio (mrq) 10.45%
Book value per share (mrq) 13.02

Cash Flow

Cash flow statement -85.93M
Levered free cash flow (LFCF) -57.25M